2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
[HTML][HTML] Autoimmune heparin‐induced thrombocytopenia
A Greinacher, K Selleng, TE Warkentin - Journal of Thrombosis and …, 2017 - Elsevier
Autoimmune heparin‐induced thrombocytopenia (aHIT) indicates the presence in patients of
anti‐platelet factor 4 (PF4)–polyanion antibodies that are able to activate platelets strongly …
anti‐platelet factor 4 (PF4)–polyanion antibodies that are able to activate platelets strongly …
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association
JF Meschia, C Bushnell, B Boden-Albala, LT Braun… - Stroke, 2014 - Am Heart Assoc
The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of stroke among individuals who have not previously …
recommendations on the prevention of stroke among individuals who have not previously …
Heparin-induced thrombocytopenia
A Greinacher - New England Journal of Medicine, 2015 - Mass Medical Soc
Key Clinical Points Heparin-Induced Thrombocytopenia Heparin-induced thrombocytopenia
(HIT) is characterized by a decrease in the platelet count of more than 50% from the highest …
(HIT) is characterized by a decrease in the platelet count of more than 50% from the highest …
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
The emergence of publications on extracellular RNA (exRNA) and extracellular vesicles
(EV) has highlighted the potential of these molecules and vehicles as biomarkers of disease …
(EV) has highlighted the potential of these molecules and vehicles as biomarkers of disease …
The pathophysiology of thrombocytopenia in chronic liver disease
O Mitchell, DM Feldman, M Diakow… - … medicine: evidence and …, 2016 - Taylor & Francis
Thrombocytopenia is the most common hematological abnormality encountered in patients
with chronic liver disease (CLD). In addition to being an indicator of advanced disease and …
with chronic liver disease (CLD). In addition to being an indicator of advanced disease and …
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review
TE Warkentin, M Pai, LA Linkins - Blood, The Journal of the …, 2017 - ashpublications.org
Direct oral anticoagulants (DOACs) are attractive options for treatment of heparin-induced
thrombocytopenia (HIT). We report our continuing experience in Hamilton, ON, Canada …
thrombocytopenia (HIT). We report our continuing experience in Hamilton, ON, Canada …
Targeting CXCR4 in AML and all
D Cancilla, MP Rettig, JF DiPersio - Frontiers in oncology, 2020 - frontiersin.org
The interaction of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
blasts with the bone marrow microenvironment regulates self-renewal, growth signaling, as …
blasts with the bone marrow microenvironment regulates self-renewal, growth signaling, as …
How I treat heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia is a prothrombotic adverse drug effect induced by
platelet-activating antibodies against multimolecular complexes of platelet factor 4 and …
platelet-activating antibodies against multimolecular complexes of platelet factor 4 and …
Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity
Antibodies recognizing complexes of the chemokine platelet factor 4 (PF4/CXCL4) and
polyanions (P) opsonize PF4-coated bacteria hereby mediating bacterial host defense. A …
polyanions (P) opsonize PF4-coated bacteria hereby mediating bacterial host defense. A …